Theratechnologies (THTX) Issues Update on Preclinical Oncology Research Program
Go back to Theratechnologies (THTX) Issues Update on Preclinical Oncology Research Program| Blyth, Inc. (NASDAQ: TH) | Delayed: 15.46 -0.56 (3.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.02 | 52 Week High | $1.54 | |||
| Open | $15.89 | 52 Week Low | $0.38 | |||
| Day High | $15.95 | P/E | 55.21 | |||
| Day Low | $15.19 | EPS | $0.28 | |||
| Volume | 2,529,011 | |||||
| (NASDAQ: THTX) | Delayed: 3.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.39 | 52 Week High | $ | |||
| Open | $3.39 | 52 Week Low | $ | |||
| Day High | $3.39 | P/E | N/A | |||
| Day Low | $3.39 | EPS | $ | |||
| Volume | 11,611 | |||||



